Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

Oct 11, 2019

SELL
$20.31 - $24.95 $627,579 - $770,955
-30,900 Closed
0 $0
Q4 2017

Oct 11, 2019

SELL
$20.99 - $23.89 $188,910 - $215,010
-9,000 Reduced 22.56%
30,900 $708,000
Q3 2017

Oct 11, 2019

BUY
$20.07 - $21.89 $240,840 - $262,680
12,000 Added 43.01%
39,900 $873,000
Q1 2017

Oct 11, 2019

BUY
N/A
9,000 Added 47.62%
27,900 $527,000
Q4 2016

Oct 11, 2019

BUY
N/A
5,000 Added 35.97%
18,900 $304,000
Q3 2016

Oct 11, 2019

BUY
N/A
13,900
13,900 $222,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.83B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Stonehage Fleming Financial Services Holdings LTD Portfolio

Follow Stonehage Fleming Financial Services Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.